These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4746332)

  • 21. A review of pharmacological approaches to the acetylcholine receptors at the neuromuscular junction.
    Waud DR
    Ann N Y Acad Sci; 1971 Sep; 183():147-57. PubMed ID: 4330758
    [No Abstract]   [Full Text] [Related]  

  • 22. The effects of roxatidine on neuromuscular transmission.
    Bossa R; Chiericozzi M; Galatulas I; Salvatore G; Teli M; Baggio G; Castelli M
    In Vivo; 1995; 9(2):113-5. PubMed ID: 7548786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of muscle relaxants under general anesthesia. A "transient-state concept" of muscle relaxant-receptor interaction].
    Schuh FT
    Fortschr Med; 1981 Jun; 99(22):869-73. PubMed ID: 7262766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction among agents that block end-plate depolarization competitively.
    Waud BE; Waud DR
    Anesthesiology; 1985 Jul; 63(1):4-15. PubMed ID: 2409846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Steroidal neuromuscular blocking agents.
    Buckett WR
    Adv Drug Res; 1975; 10():53-92. PubMed ID: 816179
    [No Abstract]   [Full Text] [Related]  

  • 26. The potentiation of the neuromuscular blocking activity of hexafluorenium and d-tubocurarine by volatile anaesthetics.
    Vermeer GA; Hess SW
    Anaesthesist; 1974 Feb; 23(2):72-8. PubMed ID: 4458482
    [No Abstract]   [Full Text] [Related]  

  • 27. Neuromuscular blocking agents: structural modification of (+)-tubocurarine and (minus)-curarine.
    Marshall IG; Murray JB; Smail GA; Stenlake JB
    J Pharm Pharmacol; 1967 Dec; 19():Suppl:53S-70S. PubMed ID: 4383858
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro measurement of margin of safety of neuromuscular transmission.
    Waud DR; Waud BE
    Am J Physiol; 1975 Dec; 229(6):1632-4. PubMed ID: 1211496
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine.
    Miller RD; Crique M; Eger EI
    Anesthesiology; 1976 Mar; 44(3):206-10. PubMed ID: 1267887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kinetic and empirical analysis of dose-response curves illustrated with a cardiac example.
    Waud DR; Son SL; Waud BE
    Life Sci; 1978 Apr 3-17; 22(13-15):1275-85. PubMed ID: 661504
    [No Abstract]   [Full Text] [Related]  

  • 31. Neuromuscular blocking activity of 6-phenylphenanthridine-3,8-bis-(tri-methylammonium) iodide (compound 76-805).
    Mukherjee KC; Patnaik GK; Rastogi SN; Dubey MP; Dhawan BN
    Indian J Exp Biol; 1988 Jul; 26(7):535-7. PubMed ID: 3198155
    [No Abstract]   [Full Text] [Related]  

  • 32. [Structural and stereochemical aspects of neuromuscular blockage by isomers and derivatives of tubocurarine].
    Stenlake JB
    Ann Pharm Fr; 1968 Mar; 26(3):185-92. PubMed ID: 5719758
    [No Abstract]   [Full Text] [Related]  

  • 33. The kinetics of inhibition of nicotinic acetylcholine receptors by (+)-tubocurarine and pancuronium.
    Wenningmann I; Dilger JP
    Mol Pharmacol; 2001 Oct; 60(4):790-6. PubMed ID: 11562442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time course of muscle relaxation with a combination of pancuronium and tubocurarine.
    Mirakhur RK; Pandit SK; Ferres CJ; Gibson FM
    Anesth Analg; 1984 Apr; 63(4):437-40. PubMed ID: 6703370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of succinylcholine, decamethonium, hexacarbacholine, gallamine and dimethyl tubocurarine on the twitch and tonic neuromuscular systems of the cat.
    Katz RL; Eakins KE
    J Pharmacol Exp Ther; 1966 Nov; 154(2):303-9. PubMed ID: 5922992
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of pipecuronium bromide during halothane or enflurane anesthesia--a comparison with pancuronium regarding the optimal dose and the effect of volatile anesthetics on neuromuscular blockade].
    Amaki Y; Yamamura H
    Masui; 1993 Jun; 42(6):876-82. PubMed ID: 8391589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lithium and neuromuscular transmission.
    Waud BE; Farrell L; Waud DR
    Anesth Analg; 1982 May; 61(5):399-402. PubMed ID: 6278988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Combination of non-depolarizing muscle relaxants. Studies in rats (author's transl)].
    Plötz J; Weis KH; Decker R
    Anaesthesist; 1974 Apr; 23(4):197-201. PubMed ID: 4477695
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical study of pancuronium bromide--cumulation effect and interaction with halothane].
    Amaki Y; Uchida M; Kobayashi K
    Masui; 1972 Nov; 21(12):1227-31. PubMed ID: 4265509
    [No Abstract]   [Full Text] [Related]  

  • 40. Porcine malignant hyperthemia IV: Neuromuscular blockade.
    Hall GM; Lucke JN; Lister D
    Br J Anaesth; 1976 Dec; 48(12):1135-41. PubMed ID: 1023949
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.